Terms: = Cervical cancer AND KRAS, C-K-RAS, 3845, P01116, NS3, KI-RAS, KRAS2, K-RAS4A, K-RAS2A, K-RAS4B, KRAS1, K-RAS2B, RASK2 AND Treatment
40 results:
1. Exploring a novel seven-gene marker and mitochondrial gene TMEM38A for predicting cervical cancer radiotherapy sensitivity using machine learning algorithms.
Wang J; Mou X; Lu H; Jiang H; Xian Y; Wei X; Huang Z; Tang S; Cen H; Dong M; Liang Y; Shi G
Front Endocrinol (Lausanne); 2023; 14():1302074. PubMed ID: 38327905
[TBL] [Abstract] [Full Text] [Related]
2. Macrofollicular Architecture in Invasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Pitfall in Thyroid Practice.
Yadav S; Kandasamy D; Damle N; Goel R; Chumber S; Sharma MC; Boruah M; Agarwal S
Head Neck Pathol; 2023 Dec; 17(4):899-909. PubMed ID: 37775618
[TBL] [Abstract] [Full Text] [Related]
3. The differences in immune features and genomic profiling between squamous cell carcinoma and adenocarcinoma - A multi-center study in Chinese patients with uterine cervical cancer.
Li J; Xue X; Zhang Y; Ding F; Wu W; Liu C; Xu Y; Chen H; Ou Q; Shao Y; Li X; Wu F; Wu X
Gynecol Oncol; 2023 Aug; 175():133-141. PubMed ID: 37356314
[TBL] [Abstract] [Full Text] [Related]
4.
Flores Legarreta A; Salvo G; Gonzales NR; Chisholm G; Hillman RT; Frumovitz M
J Gynecol Oncol; 2023 Jul; 34(4):e50. PubMed ID: 36807750
[TBL] [Abstract] [Full Text] [Related]
5. ROS1 as a possible prognostic biomarker of cervical adenocarcinoma: An exploratory analysis with next-generation sequencing.
Machida H; Matsuo K; Tanaka M; Kitatani K; Takase A; Yokoyama K; Kajiwara H; Yasaka M; Ikeda M; Yoshida H; Hirasawa T; Mikami M
Gynecol Oncol; 2023 Apr; 171():59-66. PubMed ID: 36804622
[TBL] [Abstract] [Full Text] [Related]
6. Single-cell transcriptomics dissects epithelial heterogeneity in HPV
Wang C; Li L; Wang F; Li X; Sun J; Li X; Lei T; Huang Q; Zhang G; Wang H; Li D; Jia J; Li C; Geng F; Yue J; Liu C
J Med Virol; 2023 Feb; 95(2):e28480. PubMed ID: 36609919
[TBL] [Abstract] [Full Text] [Related]
7. Small Cell and Other Rare Histologic Types of cervical cancer.
Marchocki Z; Swift B; Covens A
Curr Oncol Rep; 2022 Nov; 24(11):1531-1539. PubMed ID: 35947285
[TBL] [Abstract] [Full Text] [Related]
8. Factors associated with preoperative and postoperative seizures in patients undergoing resection of brain metastases.
Garcia JH; Morshed RA; Chung J; Millares Chavez MA; Sudhakar V; Saggi S; Avalos LN; Gallagher A; Young JS; Daras M; McDermott MW; Garcia PA; Chang EF; Aghi MK
J Neurosurg; 2023 Jan; 138(1):19-26. PubMed ID: 35535842
[TBL] [Abstract] [Full Text] [Related]
9. cervical cancer screening, abnormal results, and follow-up in women with substance use-related diagnoses.
Eastment MC; Gupta A; James J; Richardson BA; Pinder L; Kim HN; Wald A; Tsui JI
Subst Abus; 2022; 43(1):925-931. PubMed ID: 35289732
[No Abstract] [Full Text] [Related]
10. Driver gene mutations in micro-invasive cervical squamous cancers have no prognostic significance.
Kashofer K; Regauer S; Reich O; Petru E; Winter E
Gynecol Oncol; 2022 Apr; 165(1):121-128. PubMed ID: 35101299
[TBL] [Abstract] [Full Text] [Related]
11. Mutation Analysis of Radioresistant Early-Stage cervical cancer.
Oike T; Sekiguchi Y; Yoshimoto Y; Oike T; Ando K; Gu W; Sasaki Y; Tokino T; Iwase A; Ohno T
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008475
[TBL] [Abstract] [Full Text] [Related]
12. The next generation sequencing of cancer-related genes in small cell neuroendocrine carcinoma of the cervix.
Pei X; Xiang L; Chen W; Jiang W; Yin L; Shen X; Zhou X; Yang H
Gynecol Oncol; 2021 Jun; 161(3):779-786. PubMed ID: 33888337
[TBL] [Abstract] [Full Text] [Related]
13. Mutational profiles of marker genes of cervical carcinoma in Bangladeshi patients.
Sharmin S; Zohura FT; Islam MS; Shimonty A; Khan MA; Parveen R; Sharmin F; Ahsan CR; Islam ABMMK; Yasmin M
BMC Cancer; 2021 Mar; 21(1):289. PubMed ID: 33736612
[TBL] [Abstract] [Full Text] [Related]
14. Impact of COVID-19-related care disruptions on cervical cancer screening in the United States.
Burger EA; Jansen EE; Killen J; Kok IM; Smith MA; Sy S; Dunnewind N; G Campos N; Haas JS; Kobrin S; Kamineni A; Canfell K; Kim JJ
J Med Screen; 2021 Jun; 28(2):213-216. PubMed ID: 33730899
[TBL] [Abstract] [Full Text] [Related]
15. Comparative genomics of high grade neuroendocrine carcinoma of the cervix.
Hillman RT; Cardnell R; Fujimoto J; Lee WC; Zhang J; Byers LA; Ramalingam P; Leitao M; Swisher E; Futreal PA; Frumovitz M
PLoS One; 2020; 15(6):e0234505. PubMed ID: 32544169
[TBL] [Abstract] [Full Text] [Related]
16. Mesonephric-like Carcinoma of the Endometrium: A Subset of Endometrial Carcinoma With an Aggressive Behavior.
Euscher ED; Bassett R; Duose DY; Lan C; Wistuba I; Ramondetta L; Ramalingam P; Malpica A
Am J Surg Pathol; 2020 Apr; 44(4):429-443. PubMed ID: 31725471
[TBL] [Abstract] [Full Text] [Related]
17. Updates and management algorithm for neuroendocrine tumors of the uterine cervix.
Salvo G; Gonzalez Martin A; Gonzales NR; Frumovitz M
Int J Gynecol Cancer; 2019 Jul; 29(6):986-995. PubMed ID: 31263021
[TBL] [Abstract] [Full Text] [Related]
18. Results from a single arm, single stage phase II trial of trametinib and GSK2141795 in persistent or recurrent cervical cancer.
Liu JF; Gray KP; Wright AA; Campos S; Konstantinopoulos PA; Peralta A; MacNeill K; Morrissey S; Whalen C; Dillon D; Matulonis UA
Gynecol Oncol; 2019 Jul; 154(1):95-101. PubMed ID: 31118140
[TBL] [Abstract] [Full Text] [Related]
19. Tanshinone I attenuates proliferation and chemoresistance of cervical cancer in a kras-dependent manner.
Dun S; Gao L
J Biochem Mol Toxicol; 2019 Apr; 33(4):e22267. PubMed ID: 30506648
[TBL] [Abstract] [Full Text] [Related]
20. The role of genomic profiling in adolescents and young adults (AYAs) with advanced cancer participating in phase I clinical trials.
McVeigh TP; Sundar R; Diamantis N; Kaye SB; Banerji U; Lopez JS; de Bono J; van der Graaf WTA; George AJ
Eur J Cancer; 2018 May; 95():20-29. PubMed ID: 29614442
[TBL] [Abstract] [Full Text] [Related]
[Next]